Cannabis Science & Health
Dangers Lurking in Synthetic CBD Underscore Value of Quality Product
The natural healing properties of CBD are being jeopardized by the advent of man-made synthetic CBDs.
DEA Permits Further Cannabinoid-based Pharma Research
The research is focused on developing a drug that enables patients to benefit from the medicinal benefits of THC without experiencing its inherit psychoactive properties.
Daily Cannabis Use on the Rise in American Adults
Significant increases in cannabis use among adults 65 and older defy perceptions that older adults do not use cannabis.
DEA Green-lights Novel Cannabinoid Research
The research will build on previous findings that could enhance the performance of other cancer therapeutics such as checkpoint inhibitors, which activate the immune system to destroy cancer cells.
Cannabis to be Assessed as an Alternative to Fentanyl in Pivotal Clinical Trial
The trial is designed to assess the time-to-relief in patients suffering from severe pain.
Survey of Oncologists Finds Knowledge Gap on Medical Marijuana
Though almost half of oncologists surveyed recommend medical marijuana clinically, less than a third feel equipped with enough knowledge to make such recommendations.
Enhancing the Bioavailability of Cannabinoids
Researchers are striving to develop a full-profile, non-psychoactive cannabis extract product to help meet unmet medical needs.
Cannabis Does Not Increase Suicidal Behavior In Psychiatric Patients
Recent findings contrast with pre-existing data that shows the drug is linked to an increased chance of suicidal behaviour in the general population.
Medical Cannabis and the Challenge for Regulation of Medicines
Reviews of scientific evidence show promising findings for some, but not all, conditions for which cannabis is considered a treatment – and this evidence is difficult to untangle.
